,&pc29#h\w5vD1;I'8ϲ˜>1ђ˖?͠N Ktӓ_=m9DHs\KyyL Kv$M3Ew~)=-\=EJlfc\_\>4E8:7J,J*^8OI2wqDTPDzsp8^E!)L4J#w4\O,;xDzk8lyVDrhbvUՖn[/Oh}c5mm\d:dWՍM);2xKmyJG ߔ:tVreGnyThxJ*ۆ.OcsTLJZ YqΧIJVsI_^ `ıLX!p7oFz|64GxlxvfOwhv:Ϳ]}K|68i5>XoAt/#ϝ>4yοЇVt8ku䝮ƼY8N7,5;o9k?acw'tlgM_^M#, The present study suggests that rs10835638 and rs6166 genetic variants affect hypothalamic-pituitary–gonadal hormones serum levels, and together may provide an improved model for predicting an ovarian response during COS., Studies on pharmacogenetics have demonstrated a relationship between FSHR or FSHB genotyping and drug response, suggesting a potential effect of individual genetic variability on ovarian stimulation..